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ABSTRACT 
 
Survivors of torture may have long-term physical, psychiatric and psychological sequelae. 
The aim of this study was to determine whether survivors of torture exhibit any 
psychopathology, whether they demonstrate abnormal findings on Brain Single Photon 
Emission Computed Tomography (SPECT) imaging, and whether correlations exist 
between Post Traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD), 
perfusion changes on Brain SPECT and Initial Self Reporting Questionnaire (SRQ8) 
scores.  Thirty-six volunteers were recruited in a non randomised manner. Participants 
were assessed by a psychiatrist.  The SRQ8, Impact of Event Scale – Revised (IES-R) 
and Montgomery Asberg Depression Rating Scale (MADRS) were administered. 
Participants underwent Brain SPECT imaging to assess cerebral perfusion changes. Data 
was analysed using Statistica 9.1. The primary psychiatric diagnoses made were PTSD, 
MDD or both. Participants with psychopathology had higher SRQ8, MADRS and IES-R 
scores. Although qualitatively, participants with psychopathology showed increased 
abnormal cerebral perfusion on Brain SPECT imaging, as compared to those participants 
without psychopathology, this could not be proven statistically. Perfusion changes were 
noted in the temporal cortices, parietal cortices, orbitofrontal cortices, thalami and basal 
ganglia. Higher SRQ8 scores were associated with higher scores on the MADRS and IES-
R, and hence correlated with diagnoses of MDD and PTSD, but no direct association was 
noted with the visualised abnormal Brain SPECT imaging findings. 
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CHAPTER ONE: INTRODUCTION 
 
1.1  Background 
 
There is a current and impending humanitarian crisis in the violation of human rights. 
Throughout the world, on a daily basis, deliberate and intentional physical and 
psychological harm is inflicted upon individuals.1 
 
The consequences of these actions are immense, not just for the individual victims but for 
the world as a whole. There is a significant economic, social and moral burden that is 
imposed. Deliberate and intentional harm inflicted upon individuals can cripple a country 
and its people. In Africa alone, this is clearly evident in countries such as Rwanda and 
Zimbabwe.2 The mass exodus of Zimbabweans to South Africa to escape violence and 
deteriorating socio-economic circumstances is an example that has impact on the 
individual and country as a whole.2 The influx of asylum seekers to South Africa also has 
implications for health care workers treating survivors of torture.3    
 
Numerous human rights violations have taken place in Zimbabwe over the past three 
decades but the last decade has shown the most sustained human rights violations in 
Zimbabwe‟s history.4  Events leading up to this period are briefly documented below.4,5 
In the late 1970‟s, the then Rhodesian government decided to negotiate independence for 
the country and on the 18 April 1980, Rhodesia gained independence and the country 
renamed, Zimbabwe. In 1980, the ZANU party (a liberation movement that has turned into 
a major political party) won the elections and Robert Mugabe became President of the 
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newly independent country. Initially, there was some stability but this slowly waned, socio-
economic conditions deteriorated and as a result, an opposition party called the MDC was 
founded by trade unionist, Morgan Tsvangirai, after almost twenty years of a single party 
dominance. The opposition grew in the mid 90‟s due to the worsening economic and 
human rights conditions. Natural disasters like the drought and the forcible land 
redistribution practiced by the ruling party were key factors. The rivalries between ZANU-
PF and the MDC intensified and the government (still led by Robert Mugabe) responded 
by brutally torturing and murdering opposition supporters.6 
 
Unfortunately, most of the world has chosen to ignore the atrocities committed in 
Zimbabwe over the last decade and hence they are still perpetuated, along with atrocities 
in various other parts of the world.7 
 
From a medical perspective, the research seeks to understand the impact of torture on 
brain functioning so that survivors of torture may receive better medical assistance. This 
report thus seeks to paint a clearer picture of the psychopathology of torture survivors, as 
well as highlighting the challenges for treatment.   
 
1.2  Aim 
 
To examine whether psychopathology in survivors of torture corresponds to functional 
neuroimaging and how this correlates with measures of psychopathology in terms of 
PTSD and MDD. 
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1.3  Objectives 
 
The primary objectives of the study are two-fold and relate to the psychopathology of 
survivors of torture and their functional neuroimaging findings. 
 
The primary objectives are thus to determine whether survivors of torture: 
A) exhibit any psychopathology in terms of PTSD, MDD or other psychiatric 
diagnoses. 
   B) have abnormal cerebral perfusion on Brain SPECT imaging. 
 
A secondary objective of the study is to ascertain whether correlations exist between 
PTSD, MDD, Brain SPECT imaging findings and initial SRQ8 scores. 
 
1.4  Hypothesis 
 
The hypothesis is that Brain SPECT imaging in survivors of torture reveals specific 
cerebral blood flow changes which correlate with diagnoses of PTSD and MDD as well as 
with higher SRQ8 scores. 
This hypothesis is developed through a literature review and tested through the empirical 
study of survivors of torture in Zimbabwe who are now living in South Africa. 
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1.5 Structure of the Report 
 
The rest of the research report contains the outputs of the study undertaken by the 
research on functional neuroimaging in survivors of torture.  Chapter two presents a 
review of the literature focusing on an overview of torture, psychiatric diagnoses and 
functional neuroimaging.  This is followed in chapter three by a detailed description of the 
methodology used in the research including an elaboration of specific techniques used in 
the study.  Chapter four presents the main findings of the empirical data collection carried 
out by the researcher.  Survivors of torture in Zimbabwe participated in the study and the 
collated and analysed results are presented in this chapter.  In chapter five, a discussion 
of the results and their implications are presented before the conclusion and 
recommendations in chapter six.  Supporting material in the form of references and 
appendices are included at the end of the report.   
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CHAPTER TWO: LITERATURE REVIEW 
 
2.1  Torture 
 
2.1.1 Definition of Torture 
The United Nations Convention against Torture8 defined torture as “an act or omission by 
which severe pain or suffering, whether physical or mental is intentionally inflicted on a 
person –  
(a) for such purposes as -  
      (i) obtaining from that person, or from another person, information or a confession,           
     (ii) punishing that person for an act which the person concerned or a third person has 
          committed or is suspected of having committed, or 
     (iii) intimidating or coercing that person or a third person 
OR 
(b) for any reason that is based on any form of discrimination, but does not include any 
such act that arises solely from, or is inherent in or incidental to, lawful sanctions” 
 
 
2.1.2 Incidence/Prevalence of Torture 
Despite the adoption of the United Nations Convention Against Torture and Other Cruel, 
Inhuman or Degrading Treatment or Punishment, (General Assembly Resolution 39/46, 
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December 1984)8 it is believed that as many as ninety countries worldwide undertake 
physical and/or psychological forms of torture.9 
 
Empirical research studies show that between 5% and 35% of refugees have suffered 
from some form of repressive violence or torture.10 In a study of Bosnian refugees living in 
Croatia, 18% had experienced one or more torture events, and the respondents in the 
sample reported an average of 6.5 trauma events.11  Other studies also confirm a high 
frequency of organised violence and torture.12,13,14,15 
 
African countries have also been afflicted by torture and violence. Zimbabwe is an 
example.4  A small series of epidemiological studies of torture in Mashonaland Central 
Province in Zimbabwe estimated that one adult in ten over the age of thirty was a survivor 
of torture.16  More recently, in an analysis done by the ZTVP (February 2005 – April 2006), 
of 267 Zimbabweans who sought assistance from the ZTVP over an 18 month period, 
40% of them reported having been victims of one torture incident, 41% reported two 
incidents and 19% reported three or more incidents.17 A total of 40, 559 human rights 
violations in Zimbabwe have been reported by the Human Rights Forum between July 
2001 and 2008.4         
 
2.1.3 Types of Torture 
There are different types of torture that people are subjected to.  The most commonly 
experienced types are physical torture and psychological torture.  Physical torture 
includes physical assault, deprivation and sensory overstimulation.  Psychological torture 
includes verbal abuse, threats against the person and family, simulated executions and 
witnessing torture and violence. 
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2.1.4 Consequences of Torture 
The consequences of torture are numerous, not just for the individual victims or 
perpetrators but also for the world as a whole. There is a huge economic, social and moral 
burden that is imposed. Torture can cripple a country and its people. This is evidenced by 
the large number of Zimbabweans fleeing across the borders daily. In 2002, 
approximately 120 Zimbabweans applied for asylum in South Africa; in 2003 this number 
increased to approximately 2700 and this number increased threefold in 2004 to 8500.  
These numbers kept on increasing through 2005 to 16000 and in the first quarter of 2006 
alone, 7211 Zimbabweans applied for refugee status in South Africa.17,18,19 Although the 
mass exodus of Zimbabweans is not solely due to torture, it does play a significant role. 
 
From an individual viewpoint, survivors of torture may have long term physical, psychiatric 
and/or psychological sequelae. Numerous studies have looked at these sequelae.  
Common physical effects of torture include damage to muscles, ligaments and tendons; 
chronic backache; neurological problems and internal organ damage. The psychological 
effects include multiple losses, poor self-esteem, shame, guilt, relationship problems and 
identity crises. Often survivors of torture experience further traumatisation due to 
conditions in their country of exile, e.g. xenophobia. In addition, torture survivors exhibit 
various psychiatric diagnoses including PTSD, MDD, Dysthymia, Generalised Anxiety 
Disorder, Functional Psychosis, Somatoform Pain Disorders and Dissociative Amnestic 
Disorders.20,21,22,23,24,25 
 
Torture represents a traumatic experience in which horror, helplessness and 
hopelessness are extreme. Therefore it can be expected that trauma related disorders 
e.g. PTSD and MDD are present at higher rates in torture victims than in other psycho 
traumatised individuals. In the study by Van Ommeren et al 418 tortured Bhutanese 
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refugees living in Nepalese camps were compared to 392 non-tortured compatriots. 
Tortured victims were more likely to exhibit PTSD, Somatoform Pain Disorders, 
Dissociative Amnestic Disorders, MDD and Generalised Anxiety Disorder.21 Wenzel and 
his colleagues reported on a group of exiled survivors of torture presenting to an 
outpatient psychiatric department; the most frequent diagnosis in the 44 patients who 
were seen over a period of three years was PTSD (n = 40), but criteria for a diagnosis of 
other disorders were fulfilled in 34 patients, even years after the torture, mainly MDD or 
Dysthymia (n = 26). Criteria for functional psychosis were fulfilled in four patients.22 
Survivors of torture versus non-tortured political activists in Turkey had significantly more 
symptoms of PTSD and Anxiety/Depression. This suggests that torture itself has long 
term psychological effects independent of those related to uprooting, refugee status and 
other traumatic life events in a politically repressive environment.23 
 
2.2  Psychiatric Diagnoses 
 
For the purpose of this study, “psychiatric diagnoses” will include PTSD and MDD.   
 
2.2.1 Post Traumatic Stress Disorder  
PTSD is an anxiety disorder that may occur in persons who have experienced a traumatic 
event that has involved experiencing, witnessing or being confronted with actual or 
threatened death, serious physical injury, or a threat to one‟s physical integrity. The three 
major elements of PTSD include re-experiencing the trauma through dreams or recurrent 
and intrusive thoughts, emotional numbing such as feeling detached from others and 
symptoms of autonomic arousal e.g. irritability and exaggerated startle response. The 
above symptoms should be present for more than one month and the disturbance should 
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cause clinically significant distress or impairment in social, occupational or other important 
areas of functioning.26,27 
 
2.2.2 Incidence/Prevalence of PTSD 
The lifetime prevalence of PTSD is estimated to be about 8% of the general population.28  
In torture survivors, research has revealed a lifetime prevalence of PTSD of 30-54%.15,29 
 
2.2.3 Major Depressive Disorder  
DSM IV-TR states that a person must have at least five of nine criteria for a major 
depressive episode. These criteria include a depressed mood, loss of interest or pleasure, 
significant weight or appetite changes, sleep disturbances, psychomotor agitation or 
retardation, fatigue or loss of energy, feelings of worthlessness or excessive or 
inappropriate guilt, decreased concentration and recurrent suicidal thoughts, intent or 
plans. These symptoms must be present for at least two weeks, must impair social, 
occupational or other important areas of functioning and must not be due to the direct 
physiological effects of a substance or a general medical condition.26,27 
 
2.2.4 Incidence/Prevalence of MDD 
The lifetime prevalence of MDD in the general population is almost 17%.28 The lifetime 
prevalence of MDD in torture survivors is estimated at 27% in some studies.15,29   
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2.3   Functional Neuroimaging 
 
2.3.1 Brain Single Photon Emission Computed Tomography  
Brain SPECT is a perfusion study which allows the detection of injected cerebral blood 
flow radiopharmaceuticals and their perfusion into different brain areas, thereby allowing 
observation of the biochemical and physiological processes occurring in the brain.30  
 
SPECT allows us to study regional differences in cerebral blood flow within the brain.  The 
information on cerebral blood flow correlates highly with the rate of glucose metabolism 
because the rate of glucose utilisation in the brain is tightly coupled to the rate of blood 
flow. Therefore the use of either of the two provides a measure of the degree of cerebral 
functional activity. SPECT uses compounds labelled with single photon-emitting isotopes 
such as technetium-99m and iodine-123. In order to assess blood flow over the whole 
brain, tracers like 99mTc-HMPAO are used. The isotope attaches to molecules that are 
highly lipophilic and rapidly cross the blood-brain barrier and enter brain cells. Once inside 
the cell, the ligands are enzymatically converted to charged ions, which remain trapped in 
the cell. Thus, over time, the tracers are concentrated in areas of relatively higher blood 
flow.28   
 
Researchers have used functional imaging to study groups of patients with various 
psychiatric diagnoses. This has allowed a better understanding of the neurological 
underpinnings and pathophysiology of mental illness.28       
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2.3.2 Neuroimaging Findings in PTSD 
In PTSD, several different imaging techniques have been used to measure changes in 
cerebral blood flow, including Positron Emission Tomography, Brain SPECT, and 
Functional Magnetic Resonance Imaging.  Neuroimaging in PTSD, for any traumatic 
event, not necessarily torture, has revealed changes in brain structure and function that 
may underlie the symptoms. These insights have allowed PTSD to change from a 
“traumatic neurosis” to a biologically based psychological disorder. 
 
There are different findings and various inconsistencies in the neuroimaging of individuals 
with PTSD.  Older studies, many of which utilised SPECT, have identified four brain areas 
of special interest; the hyperactive amygdala, the hippocampus which in PTSD usually 
exhibits smaller volume and declarative memory deficits, the cingulate gyrus and the 
orbitofrontal cortical regions which may not be able to inhibit the hyperactive amygdala to 
trauma related stimuli.31,32,33,34,35,36,37   
 
A more recent review article by Francati et al published in 2007 highlights the most 
recorded findings in patients with PTSD, using Positron Emission Tomography, Functional 
Magnetic Resonance Imaging and SPECT as being decreased medial prefrontal cortex 
and increased amygdala activation.  Inconsistent results in relation to regions like the 
hippocampus and adjacent parahippocampal gyrus have been found.  These 
inconsistencies may be due to the wide variation of parameters in the different studies and 
the complex nature of PTSD.38 Approximately 85% of all people suffering from PTSD who 
participate in functional brain imaging studies have either been war victims or victims of 
sexual abuse.39  The majority have been suffering from PTSD for a very long time and 
exhibited relatively high rates of comorbidity or they use psychiatric medication, both of 
which are potential confounding factors. Some studies also did not include a trauma 
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exposed control group that had never developed PTSD. To generalise the key findings 
from previous studies, one needs to study varied populations with PTSD, including a wider 
spectrum of traumas, to focus on patients who have PTSD but no relevant comorbidity 
and to compare patient data with those of a traumatised control group.40 
 
2.3.3 Neuroimaging Findings in MDD 
In patients with MDD, functional neuroimaging studies have provided valuable information 
about abnormal neurophysiological activity in several brain structures.  Different brain 
regions correlate with discrete symptom components that compose the overall syndrome 
of major depression.41 Hence, although there are discrepancies between studies, 
consistent abnormalities in regional cerebral blood flow or glucose metabolism in the 
prefrontal cortex, anterior cingulate cortex, amygdala and basal ganglia in patients with 
MDD have been found.  Studies using SPECT showed that these findings tend to occur 
particularly in the left hemisphere.42,43,44 
 
2.3.4 Neuroimaging Findings in Torture Survivors 
Few studies have looked at functional neuroimaging in survivors of torture.  Only one 
study using SPECT showed that severe psychological trauma induced by torture can 
cause neurobiologic alterations that may contribute, even years after the original trauma, 
to a number of complaints commonly expressed by patients suffering from PTSD.45 There 
is little data regarding functional neuroimaging findings in survivors of torture who 
subsequently present with MDD. 
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It is in light of the above, that this study plans to look at the psychopathology exhibited by 
survivors of torture, their functional neuroimaging findings and a possible association 
between the two.  
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CHAPTER THREE: METHODOLOGY 
 
3.1  Sample 
 
3.1.1  Population 
SACST formerly known as the ZTVP, was established in February 2005. The ZTVP‟s 
mandate was to provide medical, psychosocial and legal services to primary survivors of 
organized violence and torture perpetrated in Zimbabwe from the year 2000 to date. In 
December 2006, the ZTVP became a partner project of the Centre for the Study of 
Violence and Reconciliation, until September 2007. SACST became an independent 
Section 21 Company in October 2007 and its mandate has expanded to respond to the 
needs of tortured asylum seekers and refugees from the African region as well as South 
African victims of gross human rights violations.20  
 
SACST is located in Braamfontein, Johannesburg. Volunteers were recruited from the 
ZTVP project between 2007 and 2010. 
 
3.1.2  Size 
A total of 36 volunteers were recruited to participate in the study. 15 of these participants 
had psychopathology while the remaining 21 had no psychopathology.  
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3.1.3  Inclusion Criteria  
All clients between the ages of 18 and 65 years, who were survivors of torture, who 
presented for the first time to SACST, were approached to participate in the study. Fifteen 
clients with psychopathology who had been exposed to torture and 15 clients without 
psychopathology were initially recruited to participate in the study. However, due to 
various factors (discussed under limitations) a further six controls were recruited. The 
traumatised individuals with psychopathology were individually matched as closely as 
possible, with traumatised individuals who did not have psychopathology, in terms of age 
and gender. The 15 clients with psychopathology were identified by the resident 
psychiatrist at SACST.  
 
This study therefore recruited consecutive volunteers, visiting the trauma clinic, male and 
female with or without psychopathology.  
 
3.1.4  Exclusion Criteria 
Clients were excluded if they were/had: 
 Pregnant 
 Medically unstable 
 Psychotic 
 Suicidal 
 Drug and/or Alcohol abuse/dependence 
 Past psychiatric history 
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3.2  Monitoring Tools 
 
3.2.1  Self Reporting Questionnaire 8  
As part of the clinical assessment by SACST, the SRQ8 was administered. This is a 
widely used psychiatric screening instrument developed in Zimbabwe, which investigates 
eight common symptoms in the past week. The SRQ8 was derived from the SRQ20 
developed by the World Health Organisation in 1980 to provide an instrument for reliably 
detecting non-psychotic mental disorders and is used widely in Africa as well as other 
developing countries. A cut-off of four has been used, since validation work with the SRQ8 
has shown this to be predictive of significant psychological disorder.46 Hence for this study 
a value equal or greater than four was considered significant. 
 
3.2.2  Impact of Event Scale-Revised  
The IES-R was first published in 1997 by Weiss and Marmar. It evaluates the subjective 
impact of a serious life event on a person. As an instrument, it is able to obtain reports of 
characteristic experiences from persons with PTSD or similar stress syndromes. It is a 22 
item questionnaire that also yields sub scores for hyperarousal, intrusive and avoidance 
experiences. It has a total score of 88.The reliability of this scale has been supported by 
adequate test – retest results.47 In terms of construct validity, the IES-R correlates 
reasonably well with the PTSD Checklist, a measure more closely tied to PTSD 
symptoms. A cut-off of 33 for a full scale score has been shown to provide optimum 
diagnostic accuracy against the PTSD Checklist.48 Hence for this study a value equal to or 
greater than 33 was considered to be significant. 
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3.2.3  Montgomery-Asberg Depression Rating Scale  
The MADRS is a simple, clinically orientated psychiatric rating scale that measures the 
treatment effects of antidepressants in depressive illness. It is a ten item scale with a total 
score of 60. The ten items included are all core symptoms of depressive illness. It has 
been shown to be highly reliable when compared to the Hamilton Rating Scale and can be 
used by trained nurses, psychologists and psychiatrists.49 This scale was chosen despite 
it being a measure of change as it is a simple, quick scale and includes core symptoms of 
depression. It is not a diagnostic tool and hence there is no value indicative of a diagnosis 
of depression. A study by Leentjens and colleagues found that maximum distribution 
between depressed and non-depressed patients with Parkinsons disease was reached at 
a cut-off score of 14/15 for the MADRS.50 Silberman and colleagues suggest that the 
MADRS shows good accuracy and correlation to the clinical diagnosis when a cut-off 
score of ten on the MADRS is used to recognise depression in mild to moderate 
Parkinsons disease patients.51 In a review article the optimal MADRS cut-off was less 
than or equal to four to define remission based on a narrow definition, while the optimal 
cut-off was less than or equal to nine based on a broad definition.52 Another study advised 
that MADRS less than ten should provide the clinician with a valid and reasonably 
objectifiable target for remission.53 Hence for this study a score equal to or greater than 11 
was considered to be significant. 
  
3.3  Data Collection Techniques 
 
 Subject information, both verbal and written, was given to each participant by the 
investigator (Appendix 1). The investigator was hence at hand to immediately deal 
with any questions arising.   
 Written informed consent was obtained from each participant (Appendix 2). 
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 Clinical characteristics of the participants, the SRQ8 score and information 
pertaining to the actual torture was obtained from the SACST case records 
(Appendix 3 and 4). 
 The names of the participants were not used. Instead each participant was given a 
unique identity number. 
 Each participant was assessed during a clinical interview by one of two 
psychiatrists. Both psychiatrists followed the same clerking format and made 
diagnoses based on the DSM IV-TR. Any prior history of a head injury unrelated to 
the torture was documented during this interview. 
 None of the participants received psychotrophic medications, nor formal 
psychotherapy prior to or at the time of data collection. 
 The IES-R was administered to assess the presence and severity of traumatic 
stress symptoms (Appendix 5). 
 The MADRS was also administered to measure the presence of, and severity of, 
depressive symptoms (Appendix 6). 
 The 15 study participants and 10 of the controls underwent Brain SPECT imaging, 
using 99mTc-HMPAO at the Department of Nuclear Medicine and Molecular 
Imaging of the University of the Witwatersrand. The Brain SPECT Imaging was 
then analysed by a consultant in the Department of Nuclear Medicine and 
Molecular Imaging (Appendix 7). 
 The source data was kept confidentially locked in the investigator‟s office. 
 
3.4  Data Analysis Techniques 
 
 Statistical analysis of the data was done using Statistica 9.1. 
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 A descriptive analysis of the demographic profile of the participants and their 
torture experience was noted. 
 Results were expressed as mean +/- standard deviation and median (range) when 
data was not normally distributed. 
 Comparisons were initially made between the study and control groups and the 
following variables were considered:  IES-R scores, MADRS scores, SRQ8 
scores, Right-Left Hemispheric ratios, Right-Left Thalamic ratios and Right-Left 
Temporal Lobe ratios. The Mann – Whitney Test was used for comparison of 
continuous variables not normally distributed. 
 The group was then divided based on SRQ8 scores ; group 0 with scores < 4  
and group 1 with scores ≥ 4. Comparisons between categorical variables were 
performed with a Fisher Exact Test. Comparisons were then made between the 
two groups using the above variables (IES-R scores, MADRS scores, SRQ8 
scores, Right-Left Hemispheric ratios, Right-Left Thalamic ratios and Right-Left 
Temporal Lobe ratios) with the Mann Whitney Test. 
 A value of p < 0.05 was considered significant. 
 Segmental Analysis to provide a semi-quantitative analysis of brain blood flow was 
done with the use of the Segami Neuro Matching Application Brain SPECT 
software.  
 
3.5  Financial Implications  
 
 Funding was obtained from SACST and from the University of the Witwatersrand 
Faculty Research Grant. 
 The funds were used to pay for the Brain SPECT scans. 
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3.6  Ethical Considerations 
 
 Ethical approval was obtained prior to conducting the study from the University of 
the Witwatersrand‟s Human Research Ethics Committee. The protocol was 
approved unconditionally (Appendix 8). The protocol number is M070447. 
 Permission to conduct the study was obtained from the Project Co-ordinator of 
SACST. 
 Each participant had been exposed to torture. In order to minimise the effects of 
trauma the participant may have been exposed to, by repeatedly discussing the 
torture, most details pertaining to the actual torture were obtained from the SACST 
clinical records. 
 Following the psychiatric assessment, all participants who necessitated either 
psychiatric or psychological management, were referred appropriately.  
 A psychiatrist and a therapist at SACST were available and willing to attend to any 
psychiatric or psychological problems with regards to re-traumatisation arising 
from this study. 
 
3.7  Limitations of study 
 
A major limitation of this study was the patient population. The initial proposal was to 
compare 15 participants with psychopathology with 15 participants without 
psychopathology and match them according to age and gender as closely as possible. 
The majority of participants had entered South Africa illegally and were in financial 
distress. As a result they were often unavailable to come through for the Brain SPECT 
imaging, which was usually done a few days after the psychiatric assessment; either 
because they had moved away from the area, had found temporary employment or were 
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not contactable. This was especially a problem with the control group. The study group 
tended to be more reliable probably as they were psychiatrically unwell and required 
intervention. Hence six additional control participants were recruited and even then, the 
additional six did not all attend their imaging appointments for the reasons stated above. 
 
 A further confounding factor was a technical factor that did not permit the acquisition of 
Brain SPECT in the University of Witwatersrand Department of Nuclear Medicine for a 
period of time. Hence although participants were available, their imaging could not be 
done. Four imaging results were also lost due to problems with the machines in the 
Department of Nuclear Medicine. 
 
Budgetary constraints necessitated a small sample size which in turn hampered statistical 
comparisons. 
 
None of the participants were on psychotrophic medication or received formal 
psychotherapy at the time of data collection. However, a few participants did attend a 
group psychoeducation and supportive counselling session. This may have skewed their 
findings with respect to the absence of psychopathology. 
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CHAPTER FOUR: RESULTS 
 
This section of the report presents the results of the empirical study carried out with 
survivors of torture.  As noted in the methodology, the sample was drawn from 
Zimbabwean survivors of torture residing in Johannesburg, South Africa.  The results 
present the characteristics of the sample, their experiences of torture, their 
psychopathology and results in various tests. 
  
4.1  Baseline characteristics of participants 
 
A total number of 36 participants entered the study (Table 4.1).  These were divided into a 
study group of 15 (42%) and a control group of 21 (58%).  The mean age of the 
participants was 35 years (SD = 8.6) with a minimum age of 20 and a maximum age of 51. 
The study group had a slightly lower mean age of 34 years (SD = 8.5) whilst the control 
group had a mean age of 36 years old (SD = 8.7).  Approximately two-thirds (67%) of the 
participants were male and one-third (33%) were female.  In the study group, 11 
participants were male and four were female and in the control group, 13 were male and 
eight were female.   
 
The marital status of the participants also varied with 23 (64%) participants being married; 
eight (22%) participants were single; four (11%) participants were widows, and one (3%) 
participant was divorced.  In the study group, a greater proportion of the participants were 
married (80%) as compared to the control group (53%).  At the time that this study was 
conducted, all participants were residing in the City of Johannesburg, South Africa 
although they originally lived in Zimbabwe.  29 (81%) participants resided with family or 
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friends, six (16%) participants resided at the Central Methodist Church and one (3%) 
participant had no fixed abode. 
 
Table 4.1: Baseline characteristics of participants 
Variable Total Participants Study Group Control Group 
Number of participants 36 15 21 
Age (mean) 35 34 36 
Gender (male) 24 11 13 
Marital status 
(married) 
23 12 11 
Residence (with 
friends or family) 
29 12 17 
Education (tertiary) 19 10 9 
Employed in 
Zimbabwe 
32 15 17 
Employed in South 
Africa 
6 2 4 
Handedness (right)  33 13 20 
 
Participants in both groups had different levels of education. 19 (53%) participants had 
tertiary level education, two (5%) participants had A levels, ten (28%) participants had O 
levels, and five (14%) participants had between 1-10 years of schooling. The study group 
had slightly higher levels of education than the control group as a whole.  Regardless of 
the different education levels, almost all the participants (89%) had been employed when 
they lived in Zimbabwe, all 15 of the study participants and 17 of the control participants.  
Of note, is that 12 participants were teachers (seven in the study group and five in the 
control group).  At the time of the study, only 17% of participants were employed in South 
Africa, two in the study group and four of the control participants. 
 
Overall 33 (92%) of the participants were right handed and three (8%) were left handed.  
Of the study participants, 13 (87%) were right handed and two (13%) were left handed 
whereas 20 (95%) of the control participants were right handed and one (5%) left handed. 
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4.2  Torture Experience 
 
Allegations of the actual forms of torture are shown in Table 4.2 including the percentage 
of the sample and graphically depicted in Figure 4.1.    
 
Table 4.2: Torture Experience 
Variable Total (%) Study (%) Control (%) 
Physical torture 
(sustained) 
27 (75) 10 (67) 17 (81) 
Psychological 
torture (sustained) 
36 (100) 15 (100) 21 (100) 
Physical torture 
(witness) 
32 (89) 14 (93) 18 (86) 
Psychological 
torture (witness) 
35 (97) 15 (100) 20 (95) 
 
All participants (36 in number) were subjected to psychological torture while 27 (75%) 
participants were also subjected to physical torture.  Most of the participants were also 
witness to torture with 89% witnessing physical torture and 97% witnessing psychological 
torture of others. 
 
 
Figure 4.1: Torture Experience 
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Looking at the nature of the physical torture, only one participant overall (control group) 
sustained a head injury prior to the torture experience.  This same participant also 
sustained a head injury during the torture.  During the torture experience, a total of 15 
(42%) of the participants sustained head injuries; nine study participants (60% of the study 
group) and six controls (29% of the control group) (Figure 4.2).  The mechanism of head 
injuries included sustained blows to the head (10), suffocation (7) and drowning (3).  
 
 
Figure 4.2: Head injury sustained during torture 
 
Some participants sustained head injuries through multiple mechanisms (Figure 4.3).  
 
Figure 4.3: Mechanism of Head Injury 
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Nine (25%) of the participants experienced loss of consciousness secondary to the head 
injury; seven study participants and two controls. 
 
4.3  Psychopathology exhibited by study participants 
 
The participants in the study showed varied psychopathology with a significant proportion 
(53%) of participants having both MDD and PTSD (Figure 4.4).   
 
Figure 4.4: Psychopathology exhibited in the participants 
 
Overall, MDD was a commoner finding than PTSD (12 versus 10 participants).  Other 
forms of psychopathology include Complicated Bereavement and Adjustment Disorder 
with depressed mood only. 
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4.4  Rating scale results  
 
Mean scores for the SRQ8, MADRS and IES-R, for all participants were significant (≥ 4, ≥ 
11 and ≥ 33 respectively). The mean score for the SRQ8 test was 4.7 ± 1.9 with a 
difference between the study (5.8 ± 1.2) and control groups (4.0 ± 2.0), however both 
scores were significant. The MADRS and IES-R scores for the study group were 
significant while the scores for the control group were not (Table 4.3 and Table 4.4). 
Table 4.3: Rating scales mean ± standard deviations 
Variable Total Study Control 
SRQ8 4.7 ± 1.9 5.8 ± 1.2 4.0 ± 2.0 
MADRS 11.7 ± 13.1 25.1 ± 9.4 2.2 ± 3.1 
IES-R 34.3 ± 25 52 ± 20.7 21.7 ± 19.7 
 
Table 4.4: Rating scales median (range) 
Variable Total Study Control 
MADRS (0 – 38) 28 (10 – 38) 0 (0 – 10) 
IES-R (2 – 79) 58 (9 – 79) 15 (2 – 70) 
 
The differences between the study and control groups with respect to the following were 
statistically significant :- 
 SRQ8   : p = 0.0078 
 MADRS : p < 0.0001 
 IES-R     : p = 0.001  
Appendix 9 provides the details of the SRQ8, MADRS and IES-R scores. 
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4.5  Correlations with SRQ8 scores 
 
Participants in the study group had higher and clinically significant SRQ8 scores (≥4) as 
compared to those in the control group, (p = 0.0007) (Figure 4.5). 
 
 
Figure 4.5: SRQ8 scores of the participants 
 
Those participants with SRQ8 scores ≥ 4 (clinically significant) had clinically and 
statistically significant MADRS (≥ 11) and IES-R (≥ 33) scores as compared to the group 
with SRQ8 scores < 4 (Table 4.5). 
 
Table 4.5: Rating scales mean ± standard deviations in participants with SRQ8              
scores < 4 and ≥ 4 
Variable SRQ8 < 4 SRQ8 ≥ 4 P Value 
MADRS 2.4 ± 3.1 15.8 ± 13.7 0.015 
IES-R 18.2 ± 18.5 41.4 ± 24.4 0.01 
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4.6  Brain SPECT imaging results 
 
Of the 36 participants in the study, 21 participants underwent Brain SPECT imaging 
(Figure 4.6).  It was not possible to complete imaging for 11 of the patients, as they did not 
present for the imaging, and four scans were lost. Approximately 80% of the study group 
underwent Brain SPECT imaging while 43% of the control group underwent the Brain 
SPECT imaging. 
 
Figure 4.6: Number and percentage of participants who underwent Brain SPECT imaging  
 
4.6.1 Quantitative results  
The hemispheres, thalami and temporal lobes were assessed in terms of their right to left 
ratios for all patients (Table 4.6). The differences in the mean scores for the study and 
control groups were not statistically significant. The p values were as follows :- 
o R-L Hemisphere ratio : p = 0.86 
o R-L Thalamus ratio : p = 0.20 
o R-L Temporal Lobe ratio : p = 0.65 
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Table 4.6: Mean ± Standard Deviations between the Right and Left Brain  
Variable Total Study Control 
R-L Hemisphere 
ratios 
0.979 (0.203) 0.946 (0.269) 1.022 (0.018) 
R-L Thalamus ratios 0.996 (0.062) 1.013 (0.063) 0.974 (0.057) 
R-L Temporal Lobe 
ratios 
1.027 (0.062) 1.036 (0.067) 1.015 (0.058) 
 
The differences in mean scores for participants with and without clinically significant 
SRQ8 scores were also not statistically significant (Table 4.7). 
 
Table 4.7: Right and Left Brain mean ± standard deviations in participants with 
SRQ8 scores < 4 and ≥ 4 
Variable SRQ8 < 4 SRQ8 ≥ 4 P Value 
R-L Hemisphere 
ratios 
1.016 ± 0.016 0.964 ± 0.241 0.47 
R-L Thalamus ratios 0.982 ± 0.064 1.002 ± 0.063 0.73 
R-L Temporal Lobe 
ratios 
1.024 ± 0.068 1.028 ± 0.063 0.79 
 
Please see appendix 10 for quantitative values. 
 
4.6.2 Qualitative results (Visual assessment) 
The participants with psychopathology showed increased abnormalities in cerebral 
perfusion on Brain SPECT imaging as compared to those participants without 
psychopathology. All 12 study participants, who underwent Brain SPECT imaging, had 
perfusion abnormalities (Figure 4.7). Four of the nine control participants, who underwent 
Brain SPECT imaging, also had perfusion abnormalities while the other five controls had 
normal imaging (Figure 4.8). Perfusion abnormalities were detected in most participants in 
the temporal cortices. To a lesser extent; the parietal cortices, orbitofrontal cortices, 
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thalami and basal ganglia were also involved. There was no difference between the study 
and control participants with respect to the areas of the brain involved. The right and left 
sides of the brain were equally involved. Please see Appendix 7 for qualitative results. 
 
 
Figure 4.7: Abnormal Brain SPECT scan (Study group) 
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Figure 4.8: Normal Brain SPECT scan (Control group) 
 
4.7  Summary of results 
 
Study participants displayed psychopathology. The clinical interviews conducted by the 
psychiatrists revealed that the commonest finding was that of MDD in 12 of the 15 study 
participants, followed closely by PTSD in 10 participants. This finding was supported by 
the rating scale scores. The mean MADRS score for all participants was 11.7 ± 13.1 and 
the mean IES-R score was 34 ± 25. 
 
The quantitative results for the Brain SPECT imaging were not statistically significant but 
the qualitative results revealed that participants with psychopathology had a visible 
abnormal cerebral perfusion specifically involving the temporal cortices, thus the reason 
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for the quantitative assessment of this cerebral area. The parietal cortices, orbitofrontal 
cortices, thalami and basal ganglia were also involved. 
 
All participants had clinically significant SRQ8 scores (mean = 4.7 ± 1.9), though the score 
in those with psychopathology was higher to a statistically significant degree than that in 
the control group. In addition, those participants with higher SRQ8 scores (≥4) had 
clinically and  statistically significant MADRS and IES-R scores, as compared to the group 
with lower SRQ8 scores. There was however, no statistical difference with respect to 
quantitative Brain SPECT imaging findings in those with SRQ8 scores < 4 and ≥ 4. 
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CHAPTER FIVE: DISCUSSION 
 
5.1  Baseline characteristics of participants 
 
The majority of participants exposed to torture were male, married and had been 
employed in their home countries. This is generally in keeping with the literature.16,25 Most 
torture survivors have had some schooling, albeit usually between one and ten years. In 
the study, 53% of participants had received tertiary education and 33% were teachers in 
Zimbabwe. This may be explained by the political situation in Zimbabwe currently as 
anecdotal reports suggest that a number of highly educated individuals particularly 
teachers are presumed to be MDC supporters and hence are the targets of torture 
attacks. 
 
5.2  Torture Experience 
 
All participants endured psychological torture while 75% were also physically tortured. 
Reeler in his report entitled „Subliminal terror?‟ makes mention of a series of unpublished 
reports by the Amani Trust which described psychological torture as being the most 
common form of torture.4 The study supports this finding. In the study, 42% of those 
physically tortured sustained head injuries. The majority of the study participants (60%) 
were included in this head injury group. A review by Mollica et al54 found that numerous 
studies of torture survivors and survivors of mass violence have linked psychiatric 
symptoms, neurologic impairment and traumatic head injury. One study showed that 
structural deficits in prefrontotemporal brain regions were linked to traumatic head injury 
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exposures and that these brain lesions were associated with symptom severity of 
depression.54 This current study did not look specifically at the correlations between 
traumatic head injuries, psychopathology and brain imaging findings. This could possibly 
have added further value to the research and suggests an opportunity for further research. 
It is also interesting to note that 97% of the sample witnessed psychological torture being 
inflicted upon others and 89% witnessed physical torture being inflicted upon others. This 
suggests repeated trauma exposure which in itself may predispose to and perpetuate 
psychological and psychiatric disorders. Subramaney in her article highlighting 
experiences of a trauma clinic showed that individuals who experienced more than one 
traumatic event were more likely to have developed PTSD than those who experienced a 
single event.55 
 
5.3  Psychopathology exhibited by study participants 
 
The findings with regards to psychopathology in torture survivors in this research support 
published research that MDD and PTSD are often found in these individuals.20,21,22,23,24,25 
PTSD develops secondary to a traumatic event and hence one would expect that more 
participants would have PTSD than MDD. However, 80% of the study group had MDD 
while 67% of the study group had PTSD. This finding is supported by literature.55 
Subramaney suggests that this maybe due to a variety of factors including the nature of 
the trauma experienced, the nature of the diagnostic criteria used and underreporting of 
symptoms.55 Both MDD and PTSD were present in 53% of the study group. The high 
comorbidity between MDD and PTSD has also been found in other studies.55 A slight bias 
in the results of this study is expected, as the study participants were chosen on the basis 
of them having psychopathology.  
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5.4  Rating scale results 
 
All study participants had significant SRQ8 (≥ 4), MADRS (≥ 11) and IES-R (≥ 33) scores. 
The significant MADRS and IES-R scores correspond well with diagnostic interview 
findings. Five of the 21 control participants did have significant IES-R scores ≥ 33, but on 
diagnostic interview they did not meet DSM IV-TR criteria27 for PTSD. This may be 
because of the subjectivity of PTSD as a clinical entity. None of the control participants 
had MADRS scores ≥ 11. The use of the MADRS to aid in detecting depression is 
debatable. In this study the clinical interview and rating scale scores corresponded well 
and hence it was not felt that the choice of MADRS was a limitation. 
 
5.5  Correlations with SRQ8 scores 
 
The SRQ8 has been shown to be reliable and predictive of psychological disorders.46 This 
was supported by the study as those with SRQ8 scores ≥ 4 had clinically significant 
MADRS and IES-R scores, which in turn tallied with greater diagnoses of MDD and 
PTSD. 
 
5.6  Brain SPECT imaging results 
 
The hemispheres, thalami and temporal lobes were the areas chosen to concentrate on 
with regards to the quantitative assessment due to changes on cerebral perfusion noted 
with visual assessment of Brain SPECT images performed in this group of participants. 
Although these areas do encompass the regions of interest in MDD and PTSD highlighted 
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in the literature, 31,32,33,34,35,36,37,42,43,44 they do not focus on the specific regions. This then 
may have contributed to the lack of statistically significant differences on imaging between 
those with and without psychopathology as well as those with SRQ8 scores < 4 and  ≥ 4. 
The sample size in the study is the most likely reason for the lack of statistically valid 
significance in the statistical analysis. It could also be that brain imaging changes occur in 
torture survivors irrespective of the presence or absence of psychopathology. However, 
this is unlikely, as the qualitative results do reveal increased cerebral perfusion 
abnormalities in those with psychopathology as compared to those without 
psychopathology.  
 
The qualitative brain imaging results for all study participants showed evidence of 
perfusion changes. All control participants except four, had normal perfusion patterns. 
One of these four was in fact HIV positive while another, although undiagnosed, had 
symptoms suggestive of HIV infection. The HIV infection could thus be the reason for the 
perfusion abnormalities detected.56  A third participant from the control group with 
abnormal perfusion findings later went on to develop PTSD though he had no evidence of 
PTSD at the time of the data collection, except for an IES-R of 59. In addition, this same 
participant had sustained a head injury, albeit without loss of consciousness, during the 
torture which may, in itself, have been responsible for the perfusion changes. Although it 
could not be explained from the data collected why the fourth control participant had 
abnormal perfusion the following possibilities need to be considered :- delayed onset of 
PTSD still to come and the subjectivity of PTSD as a clinical entity. It is hence probable 
that this participant may still develop PTSD.  
 
In the study, most perfusion abnormalities were seen in the temporal cortices. The parietal 
cortices, orbitofrontal cortices, thalami and basal ganglia were also involved. This is 
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generally in keeping with the literature..31,32,33,34,35,36,37,41,42,43,44 Vangu et al in a South 
African setting using SPECT in patients with MDD pre-ECT showed perfusion 
abnormalities mainly in the temporal and frontal areas.57 This is supported by the study. 
Studies in persons with MDD have identified perfusion abnormalities mainly in the left 
hemisphere.42,43,44 In the study, there was equal involvement of the left and right 
hemispheres. This maybe so, because I did not differentiate between those with MDD and 
those with PTSD, but looked at a collective sample. 
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CHAPTER SIX: CONCLUSION AND RECOMMENDATIONS 
 
Survivors of torture do exhibit psychopathology especially PTSD and MDD. There 
appears to be a presence of cerebral perfusion abnormality on Brain SPECT imaging, 
particularly involving the temporal cortices, in those with psychopathology. The parietal 
cortices, orbitofrontal cortices, thalami and basal ganglia are also probably involved. 
Higher SRQ8 scores are associated with higher scores on the MADRS and IES-R and 
correlate with diagnoses of MDD and PTSD, but no direct association has been noted with 
the visualised abnormal Brain SPECT imaging findings. 
 
The findings from this study support the literature available and add to the limited 
knowledge base on functional neuroimaging in survivors of torture. This study also 
importantly highlights the issue that torture survivors should be assessed early and 
treated aggressively in order to alleviate the morbidity and mortality associated with 
mental illness. 
 
It is hoped that this research will  increase the awareness of the torture still being 
perpetuated in Sub-Saharan Africa and will hence assist organisations helping torture 
survivors to access funding. This study paves the way for additional research in the field 
of torture and functional neuroimaging. A larger study that may include individuals, that 
are survivors of torture from different regions of Africa, could perhaps elucidate on the 
changes on cerebral perfusion visualised in the group of participants in this study.  This 
would also provide a power that will make the statistical outcome robust enough to predict 
the presence or absence of PTSD and MDD whenever clinically doubtful of a diagnosis.  
Pre and post interventional studies using SPECT would also be useful to understand the 
  
 
40 
neurocircuitary and pathogenesis of PTSD and MDD in torture survivors. Following up the 
participants for a longer time may also allow us the opportunity to further understand the 
concept of „Delayed onset PTSD‟. In addition, it would be useful to look at correlations 
between traumatic head injuries, functional neuroimaging and psychopathology. Financial 
constraint should not be a limitation for such studies in the presence of continuous and 
increased abuse of the powerless by those who are supposed primarily to look after them. 
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APPENDIX 1: SUBJECT INFORMATION SHEET      
TITLE OF STUDY: FUNCTIONAL NEUROIMAGING IN SURVIVORS OF TORTURE 
 
SUBJECT INFORMATION SHEET 
 
Dear Client 
 
My name is Dr Thriya Ramasar and I work in the Department of Psychiatry at the 
University of Witwatersrand.  I would like to invite you to join this study.  Before you agree 
to take part in this study you should fully understand what is involved.  If you have any 
questions, which are not fully explained in this information sheet, do not hesitate to ask 
the investigator.  You should not agree to take part unless you are completely happy 
about the procedure involved. 
 
The purpose of this study is to assess if you have any evidence of mental illness and/or 
brain changes as a result of the torture you experienced.  The research involves an 
interview by a doctor as well as giving you an injection of radiotracer that will capture 
images of your brain.  You will then be put on a machine that takes images of your brain.  
Little risk is attached to this procedure.  Data obtained from this study may help in 
managing future patients with similar problems. 
 
There will be no cost to you by accepting to participate in this study.  Transport 
arrangements will be made for you to come to the Johannesburg General Hospital for the 
procedure. 
 
Should you choose not to take part in this study, your treatment will not be affected and 
your decisions will not influence your future care and continued treatment. 
 
There will be a total of 30 patients in this study.  All information obtained during the course 
of this research is strictly confidential.  Data that may be reported in scientific journals will 
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 not include any information which identifies you as a patient in this research.  The results 
of this study may be submitted to the Ethics Committee at their request.  Any information 
uncovered regarding your imaging results or state of health as a result of your 
participation in this study will be held in strict confidence. 
 
This study will seek approval from the University of Witwatersrand‟s Human Research 
Ethics Committee. 
 
Should you have any questions regarding this study, please do not hesitate to contact Dr 
Thriya Ramasar, on telephone number 011 933 9239. 
 
Thank you for your time. 
 
Thriya Ramasar 
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APPENDIX 2: WRITTEN CONSENT FORM       
 
TITLE OF STUDY: FUNCTIONAL NEUROIMAGING IN SURVIVORS OF TORTURE 
 
WRITTEN CONSENT FORM 
 
 
Name of Patient:………………………………………………………………………….…... 
 
Patient Number:……………………………………………………………………………….. 
 
The aims and procedures of this study have been explained to me by the doctor.  I have 
read and understood the subject information sheet provided. 
 
I have had the opportunity to as questions and to consider the answers given to me. 
 
I understand that participation in this study is voluntary, that I may decline my consent and 
if I choose not to participate, my decisions will not affect my treatment and further care. 
 
I hereby feely give my informed consent to take part in this study. 
 
NAME  :………………………………………………………………………………... 
DATE  :………………………………………………………………………………... 
SIGNATURE :………………………………………………………………………………... 
 
I confirm that I have fully explained the nature of the study and the procedure to the above 
named patient. 
 
NAME  :………………………………………………………………………………... 
DATE  :………………………………………………………………………………... 
SIGNATURE :………………………………………………………………………………... 
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APPENDIX 3: DATA SHEET: Functional Neuroimaging in Survivors of Torture 
Number    
Date of Assessment  
Age  
Gender  
Marital Status  
Current living circumstances  
HLOE  
Occupation  
Date of entry to SA  
Handedness  
 
 
 
Type of 
torture: 
1. Physical (to self)  
2. Psychological (to self)  
3. Physical (witnessed)  
4. Psychological 
(witnessed) 
 
 
 
Head injury: 
 
During torture 
- blow to head 
- suffocating 
- drowning 
If YES, LOC: 
 
Prior to torture  
 
Multiaxial 
Diagnosis: 
Axis I  
Axis II  
Axis III  
Axis IV  
Axis V  
SRQ8 Score (Total = 8)  
IES-R (Total = 88)  
MADRS (Total = 60)  
Brain-SPECT findings  
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APPENDIX 4: SELF REPORTING QUESTIONNAIRE (SRQ8) 
Self Reporting Questionnaire (SRQ8) 
Read each statement aloud to the patient.  Patients should be asked to respond YES or 
NO to each question.  Try to restrict discussion about each question during testing: you 
may wish to discuss the answers after the test as a whole has been given.  
[NB – these questions relate to the last 7 days] 
 
 
        YES  NO 
 
1. Do you sleep badly?     …..  …. 
 
2. Do you cry more than usual?    ….  …. 
 
3. Do you find it difficult to enjoy your daily activity?  ….  …. 
 
4. Do you find it difficult to make decisions?   ….  …. 
 
5. Is your daily work suffering?    ….  …. 
 
6. Are you unable to play a useful part in life?  ….  …. 
 
7. Has the thought of ending your life been in your mind? ….  ….. 
 
8. Do you feel tired all the time?    ….  …. 
 
 
 
TOTAL SRQ-8 SCORE:   ……… 
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APPENDIX 5: The IMPACT OF EVENT SCALE-REVISED 
Below is a list of difficulties people sometimes have after stressful life events.  Please read 
each item, and then indicate how distressing each difficulty has been for you DURING 
THE PAST SEVEN DAYS with respect to  _________________________, 
How much were you distressed or bothered by these difficulties. 
 Not at 
all 
A little bit Moderately Quite a bit Extremely 
1. Any reminder brought back 
feelings about it 
0 1 2 3 4 
2. I had trouble staying 
asleep 
0 1 2 3 4 
3. Other things kept making 
me think about it 
0 1 2 3 4 
4. I felt irritable and angry 0 1 2 3 4 
5. I avoided letting myself get 
upset when I thought about it 
or was reminded of it 
0 1 2 3 4 
6. I thought about it when I 
didn‟t mean to 
0 1 2 3 4 
7. I felt as if it hadn‟t 
happened or wasn‟t real 
0 1 2 3 4 
8. I stayed away from 
reminders about it 
0 1 2 3 4 
9. Pictures about it popped 
into my mind 
0 1 2 3 4 
10. I was jumpy and easily 
startled 
0 1 2 3 4 
11. I tried not to think about it 0 1 2 3 4 
12. I was aware that I still had 
a a lot of feelings about it, but 
I didn‟t deal with them 
0 1 2 3 4 
13. My feelings about it were 
kind of numb 
0 1 2 3 4 
14. I found myself acting or 
feeling as though I was back 
at that time 
0 1 2 3 4 
15. I had trouble galling 0 1 2 3 4 
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 Not at 
all 
A little bit Moderately Quite a bit Extremely 
asleep 
16. I had waves of strong 
feelings about it 
0 1 2 3 4 
17. I tried to remove it from 
my memory 
0 1 2 3 4 
18. I had trouble 
concentrating 
0 1 2 3 4 
19. Reminders of it caused 
me to have physical reactions 
such as sweating, trouble 
breathing, nausea, or 
pounding heart 
0 1 2 3 4 
20. I had dreams about it 0 1 2 3 4 
21. I felt watchful or on-guard 0 1 2 3 4 
22. I tried not to talk about it 0 1 2 3 4 
   
Scoring: 
Avoidance Subscale = mean of items 5,7,8,11,12,13,17,22 
Intrusion Subscale = mean of items 1,2,3,6,9,14,16,20 
Hyperarousal Subscale = mean of items 4,10,15,18,19,21 
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APPENDIX 6: MONTGOMERY- ASBERG DEPRESSION RATING SCALE (MADRS) 
Patient‟s Name:     Date: 
1. Apparent sadness 
Representing despondency, gloom and despair (more than just ordinary 
transient low spirits), reflected in speech, facial expression and posture.  
Rate by depth and inability to brighten up. 
 
0 = No sadness  
2 = Looks dispirited but does brighten up without difficulty  
4 = Appears sad and unhappy most of the time  
6 = Looks miserable all the time.  Extremely despondent.  
 
2. Reported sadness 
Representing reports of depressed mood, regardless of whether it is 
reflected in appearance or not.  Includes low spirits, despondency or the 
feeling of being beyond help and without hope. 
 
0 = Occasional sadness in keeping with the circumstances  
2 = Sad or low but brightens up without difficulty  
4 = Pervasive feelings of sadness or gloominess.  The mood is still 
influenced by external circumstances. 
 
6 = Continuous or unvarying sadness, misery or despondency.  
 
3. Inner tension 
Representing feelings of ill-defined discomfort, edginess, inner turmoil, 
mental tension mounting to either panic, dread or anguish.  Rate according 
to intensity, frequency duration and the extent of reassurance called for. 
 
0 = Placid. Only fleeting inner tension  
2 = Occasional feelings of edginess and ill-defined discomfort  
4 = Continuous feelings of inner tension or intermittent panic which the 
patient can only master with some difficulty 
 
6 = Unrelenting dread or anguish.  Overwhelming panic  
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4. Reduced sleep 
Representing the experience of reduced duration or depth of sleep 
compared to the subject‟s own normal pattern when well 
 
0 = Sleep as normal  
2 = Slight difficulty dropping off to sleep or slightly reduced, light or fitful 
sleep 
 
4 = Moderate stiffness and resistance  
6 = Sleep reduced or broken by at least 2 hours  
  
5. Reduced appetite 
Representing the feeling of a loss of appetite compared to when well.  Rate 
by loss of desire for food or the need to force oneself to eat 
 
0 = Normal or increased appetite  
2 = Slightly reduced appetite  
4 = No appetite. Food is tasteless  
6 = Needs persuasion to eat at all  
 
6. Concentration difficulties 
Representing difficulties in collecting one‟s thoughts mounting to an 
incapacitating lack of concentration.  Rate according to intensity, frequency, 
and degree of incapacity produced 
 
0 = No difficulties in concentrating  
2 = Occasional difficulties in collecting one‟s thoughts   
4 = Difficulties in concentrating and sustaining though which reduced ability 
to read or hold a conversation 
 
6 = Unable to read or converse without great difficulty  
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7. Lassitude 
Representing difficulty in getting started or slowness in initiating and 
performing everyday activities 
 
0 = Hardly any difficulty in getting started.  No sluggishness  
2 = Difficulties in starting activities  
4 = Difficulties in starting simple routine activities which are carried out with 
effort 
 
6 = Complete lassitude. Unable to do anything without help  
 
8. Inability to feel 
Representing the subjective experience of reduced interest in the 
surroundings, or activities that normally give pleasure.  The ability to react 
with adequate emotion to circumstances or people is reduced 
 
0 = Normal interest in the surroundings and in other people  
2 = Reduced ability to enjoy usual interests  
4 = Loss of interest in the surroundings.  Loss of feelings for friends and 
acquaintances 
 
6 = The experience of being emotionally paralysed, inability to feel anger, 
grief or pleasure and a complete or even painful failure to feel for close 
relatives and friends 
 
 
9. Pessimistic thought 
Representing thoughts of guilt, inferiority, self-reproach, sinfulness, remorse 
and ruin 
 
0 = No pessimistic thoughts  
2 = Fluctuating ideas of failure, self-reproach or self-depreciation  
4 = Persistent self-accusations, or definite but still rational ideas of guilt or 
sin.  Increasingly pessimistic about the future 
 
6 = Delusions of ruin, remorse or irredeemable sin.  Self-accusations which 
are absurd and unshakable. 
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10. Suicidal thoughts 
Representing the feeling that life is not worth living, that a natural death 
would be welcome, suicidal thoughts, and preparations for suicide.  Suicide 
attempts should not in themselves influence the rating. 
 
0 = Enjoys life or takes it as it comes  
2 = Weary of life.  Only fleeting suicidal thoughts  
4 = Probably better off dead.  Suicidal thoughts are common, and suicide is 
considered as a possible solution, but without specific plans or intentions 
 
6 = Explicit plans for suicide when there is an opportunity.  Active 
preparations for suicide 
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APPENDIX 7: QUALITATIVE BRAIN SPECT IMAGING RESULTS 
Patient:            3 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
The right hemisphere demonstrates reduced perfusion throughout. 
Evidence of focal absent perfusion in: 
1. Right orbitofrontal cortex 
2. Right high parietal cortex 
 
Patient:            7 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1.   Right orbitofrontal cortex 
2. Right temporal cortex 
 
 Patient:            12 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1. Left temporal cortex 
2. Left mid to high parietal cortex 
 
Patient:            19 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
No evidence of focal abnormal perfusion. 
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Patient:            6 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal absent perfusion in: 
1. Right temporal cortex 
2. Left basal ganglia 
 
Patient:            11 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1.   Right temporal cortex  
2.   Left thalamus 
3.   Right orbitofrontal cortex 
 
Patient:            17 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
No evidence of focal abnormal perfusion. 
 
Patient:            4 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1.   Right anterior temporal cortex 
2.   Left basal ganglia 
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Patient:            14 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of increased perfusion in: 
1.   Right basal ganglia 
2.   Left mesial temporal cortex 
3.   Left orbitofrontal cortex 
 
Patient:            21 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
No evidence of focal abnormal perfusion 
 
Patient:            9 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1.  Right temporal cortex 
2.  Left basal ganglia 
 
Patient:            5 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1.  Left temporal cortex 
2.  Bilateral mesial temporal cortex 
3. Left thalamus 
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Patient:            13 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
 
1.   Right superior temporal cortex 
2.   Right mesial temporal cortex 
 
Patient:            20 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
No evidence of focal abnormal perfusion. 
 
Patient:            8 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1. Left temporal cortex 
 
Patient:            10 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of increased perfusion in: 
1. Left high parietal cortex 
2. Superior aspect of left temporal cortex 
There is associated reduced uptake in the left frontal cortex. 
 
Patient:            18 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
No evidence of focal abnormal perfusion. 
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 Patient:            30 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1. Right temporal cortex 
2. Right high parietal cortex 
3. Right thalamus 
 
Patient:            31 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1.  Left temporal cortex 
2. Left high parietal cortex 
3. Bilateral orbitofrontal cortex 
4. Left thalamus 
 
Patient:            34 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Inhomogenous decreased perfusion throughout 
 
Patient:            35 
The patient was in a quiet dimly lit room with an intravenous line inserted.  The tracer 
was injected with the patient lying down with eyes open.  Symmetrical and better 
cerebellar to cerebral ratio noted. 
Evidence of focal reduced perfusion in: 
1. Left temporal cortex 
2. Bilateral parietal cortex 
3. Right thalamus 
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APPENDIX 8: ETHICAL CLEARANCE FOR THE RESEARCH PROTOCOL 
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APPENDIX 9: RATING SCALE SCORES  
Identification 
No. 
Group SRQ8 Score IES-R MADRS 
1 1 6 56 38 
2 1 6 42 10 
3 1 8 52 18 
4 1 6 79 34 
5 1 6 60 18 
6 1 5 58 28 
7 1 6 19 28 
8 1 4 9 30 
9 1 8 70 12 
10 1 4 51 28 
11 1 5 59 26 
12 1 5 22 10 
13 1 6 76 38 
14 1 7 67 32 
15 1 5 60 26 
16 0 5 46 0 
17 0 2 9 0 
18 0 2 14 4 
19 0 3 48 0 
20 0 8 42 2 
21 0 6 70 8 
22 0 5 4 0 
23 0 6 11 0 
24 0 3 6 0 
25 0 5 7 0 
26 0 4 9 0 
27 0 5 22 8 
28 0 3 4 0 
29 0 2 7 2 
30 0 7 29 2 
31 0 3 59 4 
32 0 6 16 0 
33 0 3 15 4 
34 0 3 16 2 
35 0 1 20 10 
36 0 1 2 2 
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APPENDIX 10: QUANTITATIVE BRAIN SPECT IMAGING RESULTS 
ID 
Number 
Right Hemisphere 
Actual Count 
Left Hemisphere 
Actual Count 
R-L Hemisphere 
Ratio 
Right Temporal Lobe 
Actual Count  
Left Temporal Lobe  
Actual Count 
R-L Temporal 
Lobe  Ratio  
Right Thalamus 
Actual Count 
Left  Thalamus  
Actual Count 
R-L Thalamus  
Ratio 
3 21528 220580 0,097597 7865 7980 0,985589 778 761 1,022339 
4 78868 79803 0,988284 28402 28508 0,996282 2891 2643 1,093833 
5 78938 78343 1,007595 29889 30402 0,983126 2605 2537 1,026803 
6 27055 26551 1,018982 9318 7939 1,173699 910 907 1,003308 
7 34907 33614 1,038466 11792 10946 1,077289 964 1042 0,925144 
8 84268 80663 1,044692 32139 30463 1,055018 2614 2910 0,898282 
9 39761 40078 0,99209 13492 14874 0,907086 1531 1525 1,003934 
10 46087 43057 1,070372 15906 14950 1,063946 1718 1600 1,07375 
11 35908 34615 1,037354 11450 10756 1,064522 1481 1341 1,1044 
12 52464 50629 1,036244 19515 18057 1,080744 1905 1887 1,009539 
13 57924 55028 1,052628 19340 19135 1,010713 1827 1762 1,03689 
  
 
70 
ID 
Number 
Right Hemisphere 
Actual Count 
Left Hemisphere 
Actual Count 
R-L Hemisphere 
Ratio 
Right Temporal Lobe 
Actual Count  
Left Temporal Lobe  
Actual Count 
R-L Temporal 
Lobe  Ratio  
Right Thalamus 
Actual Count 
Left  Thalamus  
Actual Count 
R-L Thalamus  
Ratio 
14 33663 34594 0,973088 11577 11212 1,032554 978 1027 0,952288 
17 130605 127234 1,026494 53749 48718 1,103268 5102 5255 0,970885 
18 164636 159816 1,03016 65807 65049 1,011653 4742 4636 1,022865 
19 126485 122953 1,028726 39281 43051 0,912429 4179 4463 0,936366 
20 97756 92945 1,051762 31480 32697 0,962779 3163 3156 1,002218 
21 76960 76194 1,010053 23325 22510 1,036206 2418 2494 0,969527 
30 83597 80791 1,034732 31110 31284 0,994438 3061 3383 0,904818 
31 48035 47342 1,014638 16287 16153 1,008296 1727 1640 1,053049 
34 34512 34950 0,987468 14314 14030 1,020242 1373 1341 1,023863 
35 76773 75901 1,011489 31668 29153 1,086269 2626 2970 0,884175 
 
